Buy

ALNY Quote, Financials, Valuation and Earnings

Last price:

$258.49

Seasonality move :

25.91%

Day range:

$269.72 - $277.85

52-week range:

$144.73 - $304.39

Dividend yield:

0%

P/E ratio:

--

P/S ratio:

15.14x

P/B ratio:

312.37x

Volume:

763.3K

Avg. volume:

1.1M

1-year change:

79.19%

Market cap:

$36.1B

Revenue:

$2.2B

EPS (TTM):

-$2.09

Alnylam Pharmaceuticals SEC Filings

Company	Filed	Form Type	Description
ALNY Alnylam Pharmaceuticals	05/02/2024	10-Q	10-Q filing on 05/02/2024	View Form
ALNY Alnylam Pharmaceuticals	11/02/2023	10-Q	10-Q filing on 11/02/2023	View Form
ALNY Alnylam Pharmaceuticals	08/03/2023	10-Q	10-Q filing on 08/03/2023	View Form
ALNY Alnylam Pharmaceuticals	05/04/2023	10-Q	10-Q filing on 05/04/2023	View Form
ALNY Alnylam Pharmaceuticals	10/27/2022	10-Q	10-Q filing on 10/27/2022	View Form
ALNY Alnylam Pharmaceuticals	07/28/2022	10-Q	10-Q filing on 07/28/2022	View Form
ALNY Alnylam Pharmaceuticals	04/28/2022	10-Q	10-Q filing on 04/28/2022	View Form
ALNY Alnylam Pharmaceuticals	10/28/2021	10-Q	10-Q filing on 10/28/2021	View Form
ALNY Alnylam Pharmaceuticals	08/03/2021	10-Q	10-Q filing on 08/03/2021	View Form
ALNY Alnylam Pharmaceuticals	04/29/2021	10-Q	10-Q filing on 04/29/2021	View Form
ALNY Alnylam Pharmaceuticals	02/11/2021	10-K	10-K filing on 02/11/2021	View Form
ALNY Alnylam Pharmaceuticals	11/05/2020	10-Q	10-Q filing on 11/05/2020	View Form
ALNY Alnylam Pharmaceuticals	08/06/2020	10-Q	10-Q filing on 08/06/2020	View Form
ALNY Alnylam Pharmaceuticals	05/06/2020	10-Q	10-Q filing on 05/06/2020	View Form
ALNY Alnylam Pharmaceuticals	02/13/2020	10-K	10-K filing on 02/13/2020	View Form
ALNY Alnylam Pharmaceuticals	10/31/2019	10-Q	10-Q filing on 10/31/2019	View Form
ALNY Alnylam Pharmaceuticals	08/06/2019	10-Q	10-Q filing on 08/06/2019	View Form
ALNY Alnylam Pharmaceuticals	05/02/2019	10-Q	10-Q filing on 05/02/2019	View Form
ALNY Alnylam Pharmaceuticals	02/14/2019	10-K	10-K filing on 02/14/2019	View Form
ALNY Alnylam Pharmaceuticals	11/07/2018	10-Q	10-Q filing on 11/07/2018	View Form
ALNY Alnylam Pharmaceuticals	08/02/2018	10-Q	10-Q filing on 08/02/2018	View Form
ALNY Alnylam Pharmaceuticals	05/04/2018	10-Q	10-Q filing on 05/04/2018	View Form
ALNY Alnylam Pharmaceuticals	02/15/2018	10-K	10-K filing on 02/15/2018	View Form
ALNY Alnylam Pharmaceuticals	11/07/2017	10-Q	10-Q filing on 11/07/2017	View Form
ALNY Alnylam Pharmaceuticals	08/09/2017	10-Q	10-Q filing on 08/09/2017	View Form
ALNY Alnylam Pharmaceuticals	05/05/2017	10-Q	10-Q filing on 05/05/2017	View Form
ALNY Alnylam Pharmaceuticals	02/15/2017	10-K	10-K filing on 02/15/2017	View Form
ALNY Alnylam Pharmaceuticals	11/03/2016	10-Q	10-Q filing on 11/03/2016	View Form
ALNY Alnylam Pharmaceuticals	08/04/2016	10-Q	10-Q filing on 08/04/2016	View Form
ALNY Alnylam Pharmaceuticals	05/04/2016	10-Q	10-Q filing on 05/04/2016	View Form
ALNY Alnylam Pharmaceuticals	02/12/2016	10-K	10-K filing on 02/12/2016	View Form
ALNY Alnylam Pharmaceuticals	11/09/2015	10-Q	10-Q filing on 11/09/2015	View Form
ALNY Alnylam Pharmaceuticals	08/07/2015	10-Q	10-Q filing on 08/07/2015	View Form

Related Companies

Get ALNY Stock Alert

Signup to receive the latest stock alerts

Financial Ratios

ALNY

Sector

P/E ratio

--

23.85x

PEG ratio

--

0.00x

P/B ratio

312.37x

1.64x

Price / LTM sales

15.14x

1.58x

Growth Metrics

ALNY

Sector

Revenue growth

20.2%

5.51%

Earnings growth

--

8.33%

Revenue (5-year growth)

59.22%

8.27%

Earnings forecast

-$0.37

-$0.20

Profitability

ALNY

Sector

Profitability FY 2024

$1.9B

$54M

Return on invested capital

-26.39%

-14.46%

Return on assets

-6.58%

-11.84%

Return on equity

--

-17.25%

Earnings Date

Last Earnings Date

May

1

Next Earnings Date

Aug

1

Estimated Next Earnings Date

Jul

31

Balance Sheet

ALNY

Sector

Total cash

$2.6B

$40.4M

Short term investments

$1.7B

$34.9M

Total assets

$4.2B

$120.5M

Long term debt

$1B

$9.2M

Stock Ideas

Buy

70

Is MSFT Stock a Buy?

Market Cap: $3.2T
P/E Ratio: 37x

Buy or Sell?

Sell

40

Is AAPL Stock a Buy?

Market Cap: $2.9T
P/E Ratio: 32x

Buy or Sell?

Buy

61

Is NVDA Stock a Buy?

Market Cap: $2.9T
P/E Ratio: 40x

Buy or Sell?

Alerts

Buy

60

RGC alert for May 8

Regencell Bioscience Holdings [RGC] is up 10.54% over the past day.

Buy or Sell?

Buy

92

TPB alert for May 8

Turning Point Brands [TPB] is down 6.67% over the past day.

Buy or Sell?

Buy

74

LIVN alert for May 8

LivaNova PLC [LIVN] is up 1.33% over the past day.

Buy or Sell?

Master Safe Stock Market Strategies

Get Paid To Own Stocks. Insure Your Stocks During Downtrends. Master "The Vacation Trade".

Alnylam Pharmaceuticals SEC Filings

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Related Companies

Get ALNY Stock Alert

Financial Ratios

Growth Metrics

Profitability

Earnings Date

Balance Sheet

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

5 Investors to Follow Other Than Warren Buffett

Is BYD a Threat To Tesla Shareholders?

CVX Vs XOM Stock, Which Energy Play Is Best?

Stock Ideas

Is MSFT Stock a Buy?

Is AAPL Stock a Buy?

Is NVDA Stock a Buy?

Alerts

RGC alert for May 8

TPB alert for May 8

LIVN alert for May 8

THE #1 STOCK ANALYSIS TOOLTO MAKE SMARTER BUY AND SELL DECISIONS

Watchlist

Stock Score

Seasonality

Analyze

Covered Calls

Valuation

Smart Money

Education

E-Book

Newsletters

Companies

Dividends

Traders Library

Big Movers

Stock Ideas

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS